Annual Total Liabilities
$471.12 M
-$659.00 K-0.14%
31 December 2023
Summary:
Standard BioTools annual total liabilities is currently $471.12 million, with the most recent change of -$659.00 thousand (-0.14%) on 31 December 2023. During the last 3 years, it has risen by +$285.41 million (+153.69%). LAB annual total liabilities is now -0.14% below its all-time high of $471.78 million, reached on 31 December 2022.LAB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$192.21 M
-$6.26 M-3.16%
30 September 2024
Summary:
Standard BioTools quarterly total liabilities is currently $192.21 million, with the most recent change of -$6.26 million (-3.16%) on 30 September 2024. Over the past year, it has dropped by -$278.80 million (-59.19%). LAB quarterly total liabilities is now -59.84% below its all-time high of $478.58 million, reached on 30 June 2022.LAB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.1% | -59.2% |
| 3 y3 years | +153.7% | +5.1% |
| 5 y5 years | +103.5% | +72.8% |
LAB Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.1% | +160.8% | -59.8% | +6.4% |
| 5 y | 5 years | -0.1% | +323.7% | -59.8% | +72.8% |
| alltime | all time | -0.1% | +3503.2% | -59.8% | +1370.0% |
Standard BioTools Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $192.21 M(-3.2%) |
| June 2024 | - | $198.47 M(-0.9%) |
| Mar 2024 | - | $200.35 M(-57.5%) |
| Dec 2023 | $471.12 M(-0.1%) | $471.12 M(+0.0%) |
| Sept 2023 | - | $471.00 M(+0.4%) |
| June 2023 | - | $469.21 M(+0.1%) |
| Mar 2023 | - | $468.81 M(-0.6%) |
| Dec 2022 | $471.78 M(+161.2%) | $471.78 M(-1.2%) |
| Sept 2022 | - | $477.66 M(-0.2%) |
| June 2022 | - | $478.58 M(+91.6%) |
| Mar 2022 | - | $249.82 M(+38.3%) |
| Dec 2021 | $180.62 M(-2.7%) | $180.62 M(-1.2%) |
| Sept 2021 | - | $182.85 M(+1.7%) |
| June 2021 | - | $179.87 M(-1.3%) |
| Mar 2021 | - | $182.26 M(-1.9%) |
| Dec 2020 | $185.71 M(+67.0%) | - |
| Dec 2020 | - | $185.71 M(+8.6%) |
| Sept 2020 | - | $171.00 M(+14.3%) |
| June 2020 | - | $149.63 M(+0.6%) |
| Mar 2020 | - | $148.72 M(+33.7%) |
| Dec 2019 | $111.20 M(-52.0%) | - |
| Dec 2019 | - | $111.20 M(+4.1%) |
| Sept 2019 | - | $106.79 M(-3.9%) |
| June 2019 | - | $111.15 M(+1.8%) |
| Mar 2019 | - | $109.20 M(-52.8%) |
| Dec 2018 | $231.53 M(-9.7%) | $231.53 M(+0.7%) |
| Sept 2018 | - | $229.88 M(+2.5%) |
| June 2018 | - | $224.27 M(+1.4%) |
| Mar 2018 | - | $221.13 M(-13.8%) |
| Dec 2017 | $256.42 M | $256.42 M(+1.4%) |
| Sept 2017 | - | $252.93 M(-0.7%) |
| June 2017 | - | $254.77 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $253.97 M(+0.3%) |
| Dec 2016 | $253.16 M(-0.8%) | $253.16 M(+0.3%) |
| Sept 2016 | - | $252.45 M(-2.1%) |
| June 2016 | - | $257.77 M(+0.9%) |
| Mar 2016 | - | $255.46 M(+0.1%) |
| Dec 2015 | $255.15 M(-0.8%) | $255.15 M(+0.3%) |
| Sept 2015 | - | $254.36 M(-0.6%) |
| June 2015 | - | $255.91 M(+1.3%) |
| Mar 2015 | - | $252.58 M(-1.8%) |
| Dec 2014 | $257.14 M(+1154.3%) | $257.14 M(+0.5%) |
| Sept 2014 | - | $255.84 M(-0.0%) |
| June 2014 | - | $255.92 M(-0.5%) |
| Mar 2014 | - | $257.29 M(+1155.0%) |
| Dec 2013 | $20.50 M(+56.8%) | $20.50 M(+19.0%) |
| Sept 2013 | - | $17.23 M(+26.9%) |
| June 2013 | - | $13.58 M(+3.6%) |
| Mar 2013 | - | $13.11 M(+0.3%) |
| Dec 2012 | $13.07 M(-41.7%) | $13.07 M(-9.4%) |
| Sept 2012 | - | $14.44 M(-9.8%) |
| June 2012 | - | $16.01 M(-14.7%) |
| Mar 2012 | - | $18.77 M(-16.3%) |
| Dec 2011 | $22.43 M(-89.5%) | $22.43 M(-4.4%) |
| Sept 2011 | - | $23.45 M(+0.4%) |
| June 2011 | - | $23.35 M(-10.0%) |
| Mar 2011 | - | $25.95 M(-87.9%) |
| Dec 2010 | $213.97 M(+4.0%) | $213.97 M(+809.0%) |
| Sept 2010 | - | $23.54 M(-88.6%) |
| Dec 2009 | $205.77 M(+7.9%) | $205.77 M(+7.9%) |
| Dec 2008 | $190.69 M(+3.0%) | $190.69 M(-2.0%) |
| June 2008 | - | $194.59 M(+5.1%) |
| Dec 2007 | $185.11 M(+29.7%) | $185.11 M |
| Dec 2006 | $142.66 M | - |
FAQ
- What is Standard BioTools annual total liabilities?
- What is the all time high annual total liabilities for Standard BioTools?
- What is Standard BioTools annual total liabilities year-on-year change?
- What is Standard BioTools quarterly total liabilities?
- What is the all time high quarterly total liabilities for Standard BioTools?
- What is Standard BioTools quarterly total liabilities year-on-year change?
What is Standard BioTools annual total liabilities?
The current annual total liabilities of LAB is $471.12 M
What is the all time high annual total liabilities for Standard BioTools?
Standard BioTools all-time high annual total liabilities is $471.78 M
What is Standard BioTools annual total liabilities year-on-year change?
Over the past year, LAB annual total liabilities has changed by -$659.00 K (-0.14%)
What is Standard BioTools quarterly total liabilities?
The current quarterly total liabilities of LAB is $192.21 M
What is the all time high quarterly total liabilities for Standard BioTools?
Standard BioTools all-time high quarterly total liabilities is $478.58 M
What is Standard BioTools quarterly total liabilities year-on-year change?
Over the past year, LAB quarterly total liabilities has changed by -$278.80 M (-59.19%)